← Back to Search

Omega-3 Fatty Acid

Fish Oil, Ablation, Sinus Rhythm for Atrial Fibrillation

Phase 4
Waitlist Available
Led By Hakan Oral, MD
Research Sponsored by University of Michigan
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights

Summary

To determine if peri-operative treatment with omega-3 fatty acids is associated with a decrease in the incidence of early recurrences of atrial arrhythmias (within 30 days) and an improvement in probability of long-term maintenance of sinus rhythm after radiofrequency catheter ablation for Atrial Fibrillation.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of Participants With Normal Sinus Rhythm (Freedom From Atrial Arrhythmias)

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Fish Oil, Ablation, Sinus RhythmExperimental Treatment2 Interventions
Patients in the treatment arm will receive omega-3 fatty acids (EPA+DHA 4 gram/day) for 4 weeks before and 3 months after the ablation procedure.
Group II: placebo, Ablation, sinus rhythmPlacebo Group1 Intervention
Patients in the control arm will not receive any omega-3 fatty acids. However they will receive placebo.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Omega-3-acid ethyl esters
FDA approved

Find a Location

Who is running the clinical trial?

University of MichiganLead Sponsor
1,817 Previous Clinical Trials
6,387,350 Total Patients Enrolled
11 Trials studying Atrial Fibrillation
7,270 Patients Enrolled for Atrial Fibrillation
GlaxoSmithKlineIndustry Sponsor
4,772 Previous Clinical Trials
8,106,891 Total Patients Enrolled
9 Trials studying Atrial Fibrillation
3,637 Patients Enrolled for Atrial Fibrillation
Hakan Oral, MDPrincipal InvestigatorUniversity of Michigan Hospital
4 Previous Clinical Trials
503 Total Patients Enrolled
3 Trials studying Atrial Fibrillation
443 Patients Enrolled for Atrial Fibrillation
~1 spots leftby Aug 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top